IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Medicxi Ventures Management (Jersey) Ltd

Q4 2021 Holdings

Filed 2022-02-03 | 7 holdings | $52.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Aura Biosciences Inc(AURA)COM05153U107$51.6M3,039,89299.3%
Centessa Pharmaceuticals PLC(CNTA)SPONSORED ADS152309100$204.1K18,123,8920.4%
Merus N VCOMN5749R100$50.9K1,600,0000.1%
Vaxcyte Inc(PCVX)COM92243G108$44.9K1,887,4780.1%
Phathom Pharmaceuticals Inc(PHAT)COM71722W107$40.7K2,067,8610.1%
Checkmate Pharmaceuticals inCOM162818108$4.3K1,501,7160.0%
Obseva SACOMH5861P103$3.1K1,570,0000.0%